景嘉微(300474.SZ):副總裁胡亞華完成減持106.46萬股 擬繼續減持不超60.54萬股
格隆匯11月26日丨景嘉微(300474.SZ)公佈,公司於2020年5月7日披露了《關於部分高級管理人員減持股份的預披露公告》。截至2020年11月25日,此次減持計劃期限已屆滿。公司副總裁胡亞華共減持106.46萬股,佔公司總股本0.3534%。胡亞華仍持有公司股份1396.5489萬股,佔公司總股本4.6359%。
另外,胡亞華擬自該公告披露之日起15個交易日後至2020年12月31日(窗口期不減持),通過集中競價或大宗交易等相關法律法規認可的合法方式共減持公司股份不超過60.54萬股,即不超過公司總股本的0.2010%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.